Robaxin and Divalproex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Robaxin (methocarbamol) and Divalproex (divalproex sodium). Common drug interactions include arthralgia among females and astigmatism among males.

The phase IV clinical study analyzes what interactions people have when they take Robaxin and Divalproex. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Divalproex?

Divalproex has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 14,063 Divalproex users. Check the latest studies of Divalproex.



On Aug, 05, 2026

21 people who take Robaxin and Divalproex together, and have interactions are studied.

Robaxin and Divalproex drug interactions.

What are the common drug interactions of Robaxin and Divalproex, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Cough
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Pneumonia
  7. Spinal disorder (disease of spine a back bone)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac disorder
  10. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

male:

  1. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  2. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  4. Pilonidal cyst
  5. Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
  6. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  7. Schizoaffective disorder (a mental disorder characterized by disordered thought)
  8. Subcutaneous abscess
  9. Suicidal ideation
  10. Tardive dyskinesia (a disorder that involves involuntary movements)

What are the common drug interactions of Robaxin and Divalproex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  3. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  4. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  5. Cyst (a closed sac)
  6. Depression
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  9. Drug abuse
  10. Hallucination, visual (seeing things that aren't there)

50-59:

  1. Activities of daily living impaired
  2. Dehydration (dryness resulting from the removal of water)
  3. Diarrhoea
  4. Hyperhidrosis (abnormally increased sweating)
  5. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Anxiety
  8. Chronic kidney disease
  9. Dyspnoea (difficult or laboured respiration)
  10. Renal failure (kidney dysfunction)

60+:

  1. Arthralgia (joint pain)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Immune system disorder
  4. Infection
  5. Infusion site discomfort
  6. Infusion site swelling
  7. Pain
  8. Sinusitis (inflammation of sinus)
  9. Swelling
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 47.62%
  2. Hypergammaglobulinaemia (elevated levels of gamma globulin): 9 people, 42.86%
  3. Pain: 3 people, 14.29%
  4. Neuropathy Peripheral (surface nerve damage): 3 people, 14.29%
  5. Immune System Disorder: 3 people, 14.29%
  6. High Blood Pressure: 3 people, 14.29%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
  8. Sleep Disorder: 2 people, 9.52%
  9. Migraine (headache): 2 people, 9.52%
  10. Irritable Bowel Syndrome: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and Divalproex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Robaxin and Divalproex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Divalproex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Divalproex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol and divalproex sodium (the active ingredients of Robaxin and Divalproex, respectively), and Robaxin and Divalproex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: